Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”
Circulation · 2023
DOI: 10.1161/circulationaha.122.062624 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2023. Verfasst von Liling Deng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, Chin…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetes Mellitus, Type 2. Die Arbeit nennt 5 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and School of Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, China.
ORCID-Profile: Wuquan Deng
Zitieren
APA
Deng, L., Chen, Y., & Deng, W. (2023). Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”. Circulation. https://doi.org/10.1161/circulationaha.122.062624
Vancouver
Deng L, Chen Y, Deng W. Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”. Circulation. 2023. doi:10.1161/circulationaha.122.062624
BibTeX
@article{Deng2023,
author = {Deng, Liling and Chen, Yan and Deng, Wuquan},
title = {Letter by Deng et al Regarding Article, “Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study”},
journal = {Circulation},
year = {2023},
doi = {10.1161/circulationaha.122.062624}
}
EUVIMED